Novel anticarcinoembryonic antigen antibody-drug conjugate has antitumor activity in the existence of soluble antigen

被引：0
|
作者：
Shinmi, Daisuke [1 ]
Masuda, Kazuhiro [2 ]
机构：
[1] Kyowa Hakko Kirin Co Ltd, Antibody & Biol Res Labo, Tokyo, Japan
[2] Kyowa Hakko Kirin Co Ltd, Oncol Res Labo, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1101
引用
收藏
页码：332 / 332
页数：1
相关论文
共 50 条
  • [31] Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate
    Tuereci, Oezlem
    Kreuzberg, Maria
    Walter, Korden
    Woell, Stefan
    Schmitt, Ramona
    Yamada, Tomohiro
    Nakajo, Ikumi
    Sahin, Ugur
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
    Hamblett, KJ
    Senter, PD
    Chace, DF
    Sun, MMC
    Lenox, J
    Cerveny, CG
    Kissler, KM
    Bernhardt, SX
    Kopcha, AK
    Zabinski, RF
    Meyer, DL
    Francisco, JA
    CLINICAL CANCER RESEARCH, 2004, 10 (20) : 7063 - 7070
  • [33] Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
    Tai, Yu-Tzu
    Mayes, Patrick A.
    Acharya, Chirag
    Zhong, Mike Y.
    Cea, Michele
    Cagnetta, Antonia
    Craigen, Jenny
    Yates, John
    Gliddon, Louise
    Fieles, William
    Hoang, Bao
    Tunstead, James
    Christie, Amanda L.
    Kung, Andrew L.
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2014, 123 (20) : 3128 - 3138
  • [34] A novel dual drug antibody-drug conjugate targeting hTrop2 has synergetic anti-tumor activity by enhancing systemic immunity
    Zhu, Jie
    Zhao, Xiaobei
    Luo, Zhenwu
    Li, Eileen
    Xu, Hong
    Wu, Cindy
    Chen, Gang
    Nie, Lei
    Wang, Haibin
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [35] Development and activity of a novel antibody-drug conjugate for the treatment of P-cadherin expressing cancers
    Menezes, Daniel
    Abrams, Tinya J.
    Karim, Christopher
    Tang, Yan
    Ying, Chi
    Miller, Kathy
    Fanton, Christie
    Ghoddusi, Majid
    Wang, Zhen
    Patawaran, Montesa
    Pryer, Nancy
    Lees, Emma
    Damiano, Jason
    CANCER RESEARCH, 2015, 75
  • [36] Unmasking New Promises: Expanding the Antigen Landscape For Antibody-Drug Conjugates
    Oberoi, Honey K.
    Garralda, Elena
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4459 - 4461
  • [37] Antibody-drug conjugates targeting prostate-specific membrane antigen
    Olson, William C.
    Israel, Robert J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 : 12 - 33
  • [38] A Peptide-Duocarmycin Conjugate Targeting the Thomsen-Friedenreich Antigen Has Potent and Selective Antitumor Activity
    Cartwright, Oliver Charles
    Beekman, Andrew Michael
    Cominetti, Marco M. D.
    Russell, David A.
    Searcey, Mark
    BIOCONJUGATE CHEMISTRY, 2020, 31 (07) : 1745 - 1749
  • [39] Improving Intracellular Delivery of an Antibody-Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo
    Nessler, Ian
    Rubahamya, Baron
    Kopp, Anna
    Hofsess, Scott
    Cardillo, Thomas M.
    Sathyanarayan, Nalini
    Donnell, Jennifer
    Govindan, Serengulam V.
    Thurber, Greg M.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (03) : 343 - 353
  • [40] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Zhu, Xiao-yi
    Li, Quan-xiao
    Kong, Yu
    Huang, Ke-ke
    Wang, Gang
    Wang, Yun-ji
    Lu, Jun
    Hua, Guo-qiang
    Wu, Yan-ling
    Ying, Tian-lei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (03) : 609 - 618
12345